ERT is a global data and technology company that minimizes risk in clinical trials, helping sponsors bring treatments to patients quickly, with confidence. ERT’s solutions have supported half of FDA new product approvals since 2013 by enhancing trial oversight, enabling site optimization, increasing patient engagement, and measuring treatment efficacy while ensuring patient safety.
Precision is the first global precision medicine full service clinical research organization, purpose-built to improve the clinical research and development process for new therapeutics. Our novel approach integrates clinical operations excellence, along with laboratory expertise, and advanced data sciences to inform every step. This maximizes our clients’ insight into patient biology, delivering more predictable trial outcomes and accelerating clinical development. We apply our expertise to trials at all stages—from early development through approval—with imbedded experience in oncology and rare disease. With over 2000 people and 35 offices worldwide, we stand ready to help accelerate life-changing treatments anywhere around the globe.
Karma Oncology is an oncology specialised clinical development company. We support biotech and pharmaceutical companies by offering flexible and innovative solutions with respect to clinical development planning and clinical trial execution. Working with sponsors in the late preclinical phase to create innovative clinical development plans, we have been instrumental in securing investment for multiple companies to move into clinical trials. In the clinical phase of development, our virtual and stable team of experts across Europe and North America deliver complex oncology clinical trials. Our experience includes a wide variety of therapeutic approaches including autologous cell therapy, CAR-T and CAR-NK therapies in addition to many other types of product. In addition, our extensive oncology clinical trial experience can help to guide regulatory strategy, build strong investigator relationships, and ensure sponsors meet their objectives and timelines. We are: Knowledgeable Adaptable Reliable Motivated Accountable.
4G Clinical is a leader in randomization and trial supply management (RTSM) for the global life sciences industry, offering the only fully cloud-based, 100% configurable and flexible solution utilizing natural language processing (NLP) and integrated supply forecasting. 4G Clinical is headquartered in the Boston Biotech corridor of Wellesley, MA, with offices in Europe and Asia. For more information, please visit www.4gclinical.com
Advanced Clinical is a global clinical research services organization, providing CRO, FSP, Strategic Resourcing and Consulting Services for biopharmaceutical and medical device organizations. Our company is committed to improving all lives touched by clinical research and we address the hopes of patients and healthcare professionals with industry-leading services and technology in life sciences. Visit our website to learn more about how we deliver a Better Clinical Experience.
IDDI optimizes the clinical development of drugs, biomarkers and IVD using a unique combination of advanced biostatistics and innovative data collection technology.
IDDI covers the full spectrum of trial design, clinical data collection, management, analysis and reporting for Phase I- IV clinical trials.
- IDDI’s services include: Clinical Development Plans, Protocol Development, Randomization (IWRS/IRT) with Drug Supply Management, EDC, Medical Coding, Data Management, Biostatistics, IDMC Support, Biomarker/Diagnostics Validation, Medical Writing.
- IDDI’s therapeutic areas of expertise include oncology, ophthalmology, infectious diseases and cardiology.
- Experience: 27+ years - 980+ trials (630+ in oncology) - 20 FDA/EMA approvals to-date
- HQ in Belgium with offices in the USA ( Raleigh, NC, Boston, MA and San Francisco, CA).
Linical is a global speciality CRO headquartered in Osaka, Japan, listed in the prime segment of the Tokyo Stock exchange, and dedicated to serve its clients as a true partner in development. With more than 900 employees Linical directly covers more than 20 countries and all key markets in Asia-Pacific, Japan, Europe and N. America via its own offices.
PSI is a privately-owned, full-service contract research organization (CRO), operating globally. PSI’s reputation on the market place is that of a no-nonsense CRO, capable of saving pharmaceutical sponsors millions of development dollars by consistently meeting clinical trial timelines. PSI’s global reach supports the operations of clinical trials across multiple countries.